Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer..     ///    Characterization of two cases with ETV5 outlier expression by RNA ligase-mediated rapid amplification of cDNA ends identified one case with a TMPRSS2:ETV5 fusion and one case with a SLC45A3:ETV5 fusion. 